Concepedia
Publication | Open Access
Ixazomib inhibits myeloma cell proliferation by targeting UBE2K
17
Citations
25
References
2021
Year
In summary, ixazomib leads to impaired proliferation of myeloma cells by targeting UBE2K.
Page 1